Aster DM Healthcare Ltd. (IN:ASTERDM)
:ASTERDM
Top Page
Aster DM Healthcare Ltd.
(ASTERDM)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹672.00
▲(9.23% Upside)
Action:DowngradedDate:10/23/25
Aster DM Healthcare Ltd. has a solid financial foundation with strong profitability and effective equity utilization. However, the high P/E ratio suggests overvaluation, and the stock's technical indicators point to potential overbought conditions. Despite these concerns, the company's financial stability and positive cash flow are strengths.
Positive Factors
Diversified healthcare platform
Aster's multi‑service model (hospitals, clinics, diagnostics, pharmacies) across India and GCC creates durable revenue diversification. Cross‑sell between facilities and retail pharmacies helps stabilize volumes, improves patient lifetime value, and supports resilience versus single‑channel peers.
Negative Factors
Volatile revenue growth
Irregular revenue trends and a recent decline reduce predictability of occupancy and pricing power. For a hospital network, sustained volatility complicates capacity planning, specialist hiring and contract negotiations with payers, potentially pressuring margins if volumes slip.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified healthcare platform
Aster's multi‑service model (hospitals, clinics, diagnostics, pharmacies) across India and GCC creates durable revenue diversification. Cross‑sell between facilities and retail pharmacies helps stabilize volumes, improves patient lifetime value, and supports resilience versus single‑channel peers.
Read all positive factors
Aster DM Healthcare Ltd. (ASTERDM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹352.94B
Dividend Yield0.84%
Average Volume (3M)57.99K
Price to Earnings (P/E)152.0
Beta (1Y)0.33
Revenue Growth-36.14%
EPS Growth-93.99%
CountryIN
Employees14,016
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.10
Shares Outstanding518,121,030
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)122.33
Price to Sales (P/S)103.05
P/FCF Ratio5.31K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.03
Revenue Forecast (FY)₹56.17B
Aster DM Healthcare Ltd. Business Overview & Revenue Model
Company Description
Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare ...
How the Company Makes Money
Aster DM Healthcare makes money primarily by charging for healthcare services delivered through its facilities and by selling healthcare-related products through its pharmacy network. Key revenue streams typically include: (1) Hospital services (i...
Aster DM Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
68
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.56B | 40.69B | 36.38B | 29.52B | 102.53B | 85.23B |
| Gross Profit | 27.24B | 31.31B | 27.22B | 21.68B | 73.62B | 59.50B |
| EBITDA | 8.74B | 8.27B | 5.87B | 4.73B | 15.34B | 11.15B |
| Net Income | 3.31B | 53.78B | 1.29B | 4.25B | 5.26B | 1.48B |
Balance Sheet | ||||||
| Total Assets | 78.08B | 66.06B | 179.91B | 148.81B | 125.46B | 116.43B |
| Cash, Cash Equivalents and Short-Term Investments | 12.76B | 13.81B | 1.11B | 3.96B | 3.69B | 3.06B |
| Total Debt | 20.89B | 20.18B | 13.84B | 57.00B | 49.07B | 48.04B |
| Total Liabilities | 30.37B | 29.55B | 129.61B | 100.21B | 80.64B | 78.09B |
| Stockholders Equity | 45.33B | 34.28B | 45.60B | 44.48B | 39.53B | 33.72B |
Cash Flow | ||||||
| Free Cash Flow | 873.00M | 790.10M | -6.39B | 9.86B | 7.65B | 11.45B |
| Operating Cash Flow | 3.19B | 4.25B | 1.58B | 18.34B | 13.13B | 15.69B |
| Investing Cash Flow | -747.80M | 60.15B | -8.85B | -9.72B | -5.70B | -3.30B |
| Financing Cash Flow | -2.14B | -63.58B | 10.53B | -8.17B | -6.85B | -11.16B |
Aster DM Healthcare Ltd. Technical Analysis
Positive
615.20
Price Trends
628.58
Positive
626.50
Positive
628.49
Positive
Market Momentum
9.43
Negative
58.47
Neutral
64.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ASTERDM, the sentiment is Positive. The current price of 615.2 is below the 20-day moving average (MA) of 660.81, below the 50-day MA of 628.58, and below the 200-day MA of 628.49, indicating a bullish trend. The MACD of 9.43 indicates Negative momentum. The RSI at 58.47 is Neutral, neither overbought nor oversold. The STOCH value of 64.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ASTERDM.
Aster DM Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹350.26B | 31.59 | ― | 1.04% | 10.74% | 11.91% | |
71 Outperform | ₹358.56B | 75.82 | ― | 0.24% | 14.72% | 8.37% | |
65 Neutral | ₹265.51B | 114.01 | ― | ― | 25.74% | 1.41% | |
65 Neutral | ₹286.32B | 83.79 | ― | 0.04% | 15.78% | 15.01% | |
62 Neutral | ₹352.94B | 151.95 | ― | 0.84% | -36.14% | -93.99% | |
61 Neutral | ₹286.65B | 27.13 | ― | 1.07% | -1.51% | 14.27% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:ASTERDM
Aster DM Healthcare Ltd.
681.20
192.52
39.40%
IN:AJANTPHARM
Ajanta Pharma Limited
2,803.50
210.42
8.11%
IN:GLAND
Gland Pharma Ltd.
1,739.85
326.42
23.09%
IN:KIMS
Krishna Institute of Medical Sciences Limited
663.55
32.60
5.17%
IN:MEDANTA
Global Health Limited
1,065.20
-210.19
-16.48%
IN:NH
Narayana Hrudayalaya Ltd.
1,754.55
20.28
1.17%
Aster DM Healthcare Ltd. Corporate Events
Aster DM Healthcare Seeks Shareholder Nod via E-Voting on Director Appointment and Loan Powers
Mar 13, 2026
Aster DM Healthcare has initiated a postal ballot process to seek shareholder approval for key corporate actions, including the appointment of Dr. Mandayapurath Azad Moopen as an Executive Director and authorization to grant loans, guarantees, or ...
Aster DM Wins Strong Vote for QCIL Merger, Set to Form Top-Three Hospital Chain
Mar 11, 2026
Aster DM Healthcare has secured strong stakeholder backing for its planned amalgamation with Quality Care India Ltd., winning 96.68% shareholder approval, including a significant majority of minority shareholders, as well as support from unsecured...
Aster DM Healthcare Shareholders Clear Amalgamation with Quality Care India
Mar 11, 2026
Aster DM Healthcare Ltd. operates hospitals and other medical facilities, offering a range of healthcare services to patients in India and beyond, and its shares are listed on both BSE and NSE, giving it access to a wide base of public investors. ...
Aster DM Healthcare’s creditors clear key vote on amalgamation plan
Mar 11, 2026
Aster DM Healthcare said its unsecured trade creditors have approved a proposed Scheme of Amalgamation between Quality Care India Ltd. and Aster DM Healthcare Ltd., as directed by the National Company Law Tribunal, Hyderabad Bench. The resolution ...
Aster DM Healthcare Releases Latest Investor Presentation on Company Performance
Feb 5, 2026
Aster DM Healthcare Ltd. has released an investor presentation detailing the company’s recent performance to the stock exchanges in Mumbai. The disclosure signals ongoing engagement with shareholders and the broader market, providing investo...
Aster DM Healthcare Clears Q3 FY26 Results, New ESOP and Internal Capital Restructuring
Jan 30, 2026
Aster DM Healthcare Ltd.’s board has approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, with the statutory auditor issuing an unmodified opinion, underscoring the inte...
Aster DM Healthcare Moves to Fully Acquire MIMS, Lifts Stake Toward 100%
Jan 29, 2026
Aster DM Healthcare’s Investment and Finance Committee has approved a proposal to increase its stake in its material subsidiary, Malabar Institute of Medical Sciences Ltd. (MIMS), from 79.75% to 100% by acquiring up to an additional 20.25% e...
Aster DM Healthcare Plans Investor and Analyst Hospital Visits in Kerala
Jan 3, 2026
Aster DM Healthcare Limited has scheduled a hospital visit for a group of investors and analysts to its Aster Medcity facility in Kochi and QCIL KIMS in Trivandrum on January 8 and 9, 2026, which will include interactions with the company’s ...
Aster DM Healthcare Moves to Full Ownership of Prerana Hospital
Dec 31, 2025
Aster DM Healthcare has increased its stake in subsidiary Prerana Hospital Limited from 87% to 98.92% through a cash acquisition of an additional 11.94% equity for INR 38.36 crore, with the remaining 1.08% slated to be acquired by December 31, 202...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.